251 related articles for article (PubMed ID: 26946067)
1. Tranexamic acid in epistaxis: a systematic review.
Kamhieh Y; Fox H
Clin Otolaryngol; 2016 Dec; 41(6):771-776. PubMed ID: 26946067
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of epistaxes in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease) with tranexamic acid].
Morales-Angulo C; Pérez del Molino A; Zarrabeitia R; Fernández A; Sanz-Rodríguez F; Botella LM
Acta Otorrinolaringol Esp; 2007 Apr; 58(4):129-32. PubMed ID: 17428407
[TBL] [Abstract][Full Text] [Related]
3. Topical Tranexamic Acid for the Treatment of Acute Epistaxis: A Systematic Review and Meta-analysis.
Gottlieb M; DeMott JM; Peksa GD
Ann Pharmacother; 2019 Jun; 53(6):652-657. PubMed ID: 30577703
[TBL] [Abstract][Full Text] [Related]
4. Topical tranexamic acid for spontaneous epistaxis.
Santander MJ; Rosenbaum A; Winter M
Medwave; 2018 Dec; 18(8):e7372. PubMed ID: 30550535
[TBL] [Abstract][Full Text] [Related]
5. Tranexamic Acid for Epistaxis--A Promising Treatment That Deserves Further Study.
Clinkard D; Barbic D
CJEM; 2016 Jan; 18(1):72-3. PubMed ID: 26088087
[TBL] [Abstract][Full Text] [Related]
6. Treatment of epistaxis in hereditary hemorrhagic telangiectasia with tranexamic acid - a double-blind placebo-controlled cross-over phase IIIB study.
Geisthoff UW; Seyfert UT; Kübler M; Bieg B; Plinkert PK; König J
Thromb Res; 2014 Sep; 134(3):565-71. PubMed ID: 25005464
[TBL] [Abstract][Full Text] [Related]
7. A Systematic Review and Meta-analysis of the Effects of Topical Tranexamic Acid
Li T; Li F; Cha X; Wang S; Yan J; Wang T; Liang C; Zhuang C; Ren W; Liu H
Curr Pharm Des; 2023; 29(19):1497-1503. PubMed ID: 36786144
[TBL] [Abstract][Full Text] [Related]
8. BET 1: Tranexamic acid in epistaxis: who bloody nose?
Penrose N; May G
Emerg Med J; 2016 Nov; 33(11):823-825. PubMed ID: 28319931
[TBL] [Abstract][Full Text] [Related]
9. Tranexamic acid and bevacizumab in hereditary hemorrhagic telangiectasia patients presenting with epistaxis.
Lacout A; Marcy PY; El Hajjam M; Lacombe P
Cutis; 2013 Apr; 91(4):173-4. PubMed ID: 23763075
[No Abstract] [Full Text] [Related]
10. Therapeutic action of tranexamic acid in hereditary haemorrhagic telangiectasia (HHT): regulation of ALK-1/endoglin pathway in endothelial cells.
Fernandez-L A; Garrido-Martin EM; Sanz-Rodriguez F; Ramirez JR; Morales-Angulo C; Zarrabeitia R; Perez-Molino A; Bernabéu C; Botella LM
Thromb Haemost; 2007 Feb; 97(2):254-62. PubMed ID: 17264955
[TBL] [Abstract][Full Text] [Related]
11. Novel use of tranexamic acid to reduce the need for Nasal Packing in Epistaxis (NoPac) randomised controlled trial: research protocol.
Reuben A; Appelboam A; Barton A; Vickery PJ; Body R; Hilton M; Coppell J; Ewings P
BMJ Open; 2019 Feb; 9(2):e026882. PubMed ID: 30772866
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of tranexamic acid in a patient with hereditary hemorrhagic telangiectasia and massive epistaxis].
Pérez del Molino A; Zarrabeitia R; Fernández A; Botella LM
Med Clin (Barc); 2004 Jun; 123(3):118-9. PubMed ID: 15225479
[No Abstract] [Full Text] [Related]
13. Intranasal tranexamic acid for the treatment of hereditary hemorrhagic telangiectasia: a case report and review of treatment options.
Flanagan BA; Collins C; Parra S
Cutis; 2012 Feb; 89(2):69-72. PubMed ID: 22474728
[TBL] [Abstract][Full Text] [Related]
14. BET 1: Intravenous tranexamic acid in the treatment of acute epistaxis.
Fox H; Hunter F
Emerg Med J; 2015 Dec; 32(12):969-70. PubMed ID: 26598634
[TBL] [Abstract][Full Text] [Related]
15. The Use of Tranexamic Acid to Reduce the Need for Nasal Packing in Epistaxis (NoPAC): Randomized Controlled Trial.
Reuben A; Appelboam A; Stevens KN; Vickery J; Ewings P; Ingram W; Jeffery AN; Body R; Hilton M; Coppell J; Wainman B; Barton A
Ann Emerg Med; 2021 Jun; 77(6):631-640. PubMed ID: 33612282
[TBL] [Abstract][Full Text] [Related]
16. Topical tranexamic acid for the treatment of acute epistaxis in the emergency department.
Birmingham AR; Mah ND; Ran R; Hansen M
Am J Emerg Med; 2018 Jul; 36(7):1242-1245. PubMed ID: 29602670
[TBL] [Abstract][Full Text] [Related]
17. Medical treatment of epistaxis in hereditary hemorrhagic telangiectasia: an evidence-based review.
Halderman AA; Ryan MW; Clark C; Sindwani R; Reh DD; Poetker DM; Invernizzi R; Marple BF
Int Forum Allergy Rhinol; 2018 Jun; 8(6):713-728. PubMed ID: 29393992
[TBL] [Abstract][Full Text] [Related]
18. A new and rapid method for epistaxis treatment using injectable form of tranexamic acid topically: a randomized controlled trial.
Zahed R; Moharamzadeh P; Alizadeharasi S; Ghasemi A; Saeedi M
Am J Emerg Med; 2013 Sep; 31(9):1389-92. PubMed ID: 23911102
[TBL] [Abstract][Full Text] [Related]
19. Epistaxis complicated by rivaroxaban managed with topical tranexamic acid.
Utkewicz MD; Brunetti L; Awad NI
Am J Emerg Med; 2015 Sep; 33(9):1329.e5-7. PubMed ID: 25895714
[No Abstract] [Full Text] [Related]
20. Does Oral or Topical Tranexamic Acid Control Bleeding From Epistaxis?
Bridwell RE; April MD; Long B
Ann Emerg Med; 2019 Aug; 74(2):300-302. PubMed ID: 31060746
[No Abstract] [Full Text] [Related]
[Next] [New Search]
